Pharmacoeconomics of the new antipsychotics for the treatment of schizophrenia / Julie Magno Zito en Psychiatric Clinics of North America, Año 1998- Vol. 21 No. 1 (Marzo)

Público ISBD [artículo]  inPsychiatric Clinics of North America > Año 1998- Vol. 21 No. 1 (Marzo) . - pp. 181-202 Título : Pharmacoeconomics of the new antipsychotics for the treatment of schizophrenia Tipo de documento: texto impreso Autores: Julie Magno Zito, Autor Fecha de publicación: 2020 Artículo en la página: pp. 181-202 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Benzodiazepinas, Ensayos clínicos, Clozapina, Pirenzepina, Risperidona, Esquizofrenia. Resumen: Inevitably, the greater availability of more costly antipsychotic medications has resulted in attempts to regulate the use of these agents. Early objections over the cost of treatment with clozapine or risperidone have in part been mollified by preliminary statistics on the cost effectiveness of these agents. Link: ./index.php?lvl=notice_display&id=25074 [artículo] Pharmacoeconomics of the new antipsychotics for the treatment of schizophrenia [texto impreso] / Julie Magno Zito, Autor . - 2020 . - pp. 181-202. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Psychiatric Clinics of North America > Año 1998- Vol. 21 No. 1 (Marzo) . - pp. 181-202 Palabras clave: Benzodiazepinas, Ensayos clínicos, Clozapina, Pirenzepina, Risperidona, Esquizofrenia. Resumen: Inevitably, the greater availability of more costly antipsychotic medications has resulted in attempts to regulate the use of these agents. Early objections over the cost of treatment with clozapine or risperidone have in part been mollified by preliminary statistics on the cost effectiveness of these agents. Link: ./index.php?lvl=notice_display&id=25074

---

1 (1 - 1 / 1)